# SPRIX in 0 to 11 Year-Old Patients Undergoing Open Surgical Procedures

> **NCT02102516** · PHASE3 · COMPLETED · sponsor: **Egalet Ltd** · enrollment: 45 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** SPRIX(intranasal ketorolac tromethamine)

## Key facts

- **NCT ID:** NCT02102516
- **Lead sponsor:** Egalet Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2015-06
- **Final completion:** 2015-07
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2017-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02102516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02102516, "SPRIX in 0 to 11 Year-Old Patients Undergoing Open Surgical Procedures". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02102516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*